Changes in immune cell numbers and profile during long-term zanubrutinib treatment in treatment-naive and relapsed/refractory patients with chronic lymphocytic leukemia

被引：0
|
作者：
Andersson, Maria
Mulder, Tom
Heimersson, Kia
Sonnert-Husa, Sonja
Giertz, Annika
Karlsson, Claes
Lundin, Jeanette
Hansson, Lotta
Osterborg, Anders
Palma, Marzia
机构：
来源：
LEUKEMIA & LYMPHOMA | 2023年 / 64卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1553105
引用
收藏
页码：S23 / S24
页数：2
相关论文
共 50 条
  • [21] Single-agent ibrutinib in treatment-naive and relapsed/refractory chronic lymphocytic leukemia: a 5-year experience
    O'Brien, Susan
    Furman, Richard R.
    Coutre, Steven
    Flinn, Ian W.
    Burger, Jan A.
    Blum, Kristie
    Sharman, Jeff
    Wierda, William
    Jones, Jeffrey
    Zhao, Weiqiang
    Heerema, Nyla A.
    Johnson, Amy J.
    Luan, Ying
    James, Danelle F.
    Chu, Alvina D.
    Byrd, John C.
    BLOOD, 2018, 131 (17) : 1910 - 1919
  • [22] Clinical, Genomic Profile and Recurrent Somatic Mutations in 205 Chronic Lymphocytic Leukemia Treatment-Naive Patients
    Ferrer, Blanca
    Serrano, Alicia
    Adam, Victoria
    Navarro, Blanca
    Ivorra, Carmen
    Medina, Angeles
    Fernandez, Margarita
    Rodriguez, Alicia
    Martin, Vanesa
    Duran, Maria Soledad
    Herranz, Eduardo Rios
    Benet, Carmen
    Ruiz, Maria Angeles
    Montagud, Mario
    Navarro, Isabel
    Fernandez, Miguel
    Teruel, Ana Isabel
    Ortiz, Macarena
    Andreu, Rafael
    Amat, Paula
    Solano, Carlos
    Chaves, Javier F.
    Terol, Maria Jose
    BLOOD, 2017, 130
  • [23] Impact of long-term ibrutinib treatment on circulating immune cells in patients with chronic lymphocytic leukemia
    Solman, Isabelle
    Blum, Lisa
    Burger, Jan A.
    Kipps, Thomas J.
    Dean, James
    James, Danelle
    Mongan, Ann
    LEUKEMIA & LYMPHOMA, 2020, 61 : 47 - 48
  • [24] Optimizing Treatment of Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
    Mato, Anthony
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2022, 20 (5.5): : 581 - 583
  • [25] Disseminated Cryptococcal Infection in Treatment-Naive Patients With Chronic Lymphocytic Leukemia (CLL)
    Gujabidze, Kakha
    Hussain, Subaha Akram
    Balint, Stephanie
    Saadeh, Basel
    Yucelen, Sumeyra
    Shiferaw, Bethel
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (04)
  • [26] Early Ofatumumab Treatment For High-Risk, Treatment-Naive Patients With Chronic Lymphocytic Leukemia
    Jain, Nitin
    Keating, Michael J.
    Ferrajoli, Alessandra
    Konopleva, Marina
    Thomas, Deborah A.
    Pemmaraju, Naveen
    DiNardo, Courtney D.
    O'Brien, Susan
    Wierda, William G.
    BLOOD, 2013, 122 (21)
  • [27] Indirect comparisons of efficacy of zanubrutinib versus orelabrutinib in patients with relapsed or refractory chronic lymphocytic leukemia/small lymphocytic lymphoma or relapsed or refractory mantle cell lymphoma
    Song, Yuqin
    Zhou, Keshu
    Yang, Shenmiao
    Hu, Jianda
    Zou, Dehui
    Gao, Sujun
    Pan, Ling
    Wang, Tingyu
    Yang, Haiyan
    Zhang, Huilai
    Zhou, Daobin
    Ji, Jie
    Xu, Wei
    Feng, Ru
    Jin, Jie
    Lv, Fangfang
    Huang, Haiwen
    Fan, Xiaosi
    Xu, Sheng
    Zhu, Jun
    INVESTIGATIONAL NEW DRUGS, 2023, 41 (04) : 606 - 616
  • [28] Indirect comparisons of efficacy of zanubrutinib versus orelabrutinib in patients with relapsed or refractory chronic lymphocytic leukemia/small lymphocytic lymphoma or relapsed or refractory mantle cell lymphoma
    Yuqin Song
    Keshu Zhou
    Shenmiao Yang
    Jianda Hu
    Dehui Zou
    Sujun Gao
    Ling Pan
    Tingyu Wang
    Haiyan Yang
    Huilai Zhang
    Daobin Zhou
    Jie Ji
    Wei Xu
    Ru Feng
    Jie Jin
    Fangfang Lv
    Haiwen Huang
    Xiaosi Fan
    Sheng Xu
    Jun Zhu
    Investigational New Drugs, 2023, 41 : 606 - 616
  • [29] Molecular long-term remission with treatment with lenalidomide of chronic refractory or relapsed lymphoid leukemia
    Saada, Veronique
    HEMATOLOGIE, 2013, 19 (03): : 173 - 174
  • [30] Profile of venetoclax and its potential in the context of treatment of relapsed or refractory chronic lymphocytic leukemia
    Huber, Henriette
    Edenhofer, Simone
    Estenfelder, Sven
    Stilgenbauer, Stephan
    ONCOTARGETS AND THERAPY, 2017, 10 : 645 - 656
12345